GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Exam Corner/Intestinal Tuberculosis Vs Cronhn's disease
42

Intestinal Tuberculosis Vs Cronhn's disease

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2025

Intestinal Tuberculosis (ITB) vs Crohn's Disease (CD)

Intestinal Tuberculosis (ITB) and Crohn’s Disease (CD) are two distinct diseases that can present with similar clinical, endoscopic, and imaging findings, making differentiation challenging. Below is a detailed comparison to help distinguish between the two conditions.


1. Etiology

  • ITB: Caused by Mycobacterium tuberculosis, a bacterial infection.
  • CD: A chronic, idiopathic immune-mediated inflammatory disease of the gastrointestinal (GI) tract.

2. Geographic Distribution

  • ITB: Common in tuberculosis-endemic regions (e.g., India, Africa, Southeast Asia).
  • CD: More common in developed countries (e.g., North America, Europe).

3. Age of Onset

  • ITB: Typically affects young adults (20–40 years).
  • CD: Can occur at any age, but peak incidence is in the teens and 20s.

4. Systemic Symptoms

  • ITB: Often associated with constitutional symptoms such as fever, night sweats, weight loss, and anorexia.
  • CD: Less commonly associated with systemic symptoms; weight loss and fatigue may occur.

5. Site of Involvement

  • ITB: Predominantly affects the ileocecal region (ileum + cecum).
  • CD: Can involve any part of the GI tract (mouth to anus), with the terminal ileum being the most common site.

6. Endoscopic Features

  • ITB:
  • Transverse ulcers (oriented circumferentially).
  • Granular or nodular mucosa.
  • Caseating granulomas on biopsy.
  • Localized disease.
  • CD:
  • Longitudinal ulcers (along the bowel axis).
  • Cobblestone appearance.
  • Non-caseating granulomas on biopsy.
  • Skip lesions (patchy involvement).

7. Histopathology

  • ITB:
  • Caseating granulomas (necrosis present).
  • Coalescing granulomas.
  • Acid-fast bacilli detectable on Ziehl-Neelsen staining.
  • Positive for TB PCR.
  • CD:
  • Non-caseating granulomas (no necrosis).
  • Poorly organized granulomas.
  • Negative for acid-fast bacilli.
  • Negative for TB PCR.

8. Imaging Features

  • ITB:
  • Stierlin sign: Narrowing of the terminal ileum with a contracted cecum.
  • Enlarged, necrotic mesenteric lymph nodes.
  • Ascites may be present.
  • Calcified lymph nodes.
  • CD:
  • Long segment strictures.
  • Creeping fat: Fatty proliferation of mesentery.
  • Skip lesions.
  • No necrotic or calcified lymph nodes.

9. Granuloma Characteristics

  • ITB: Large granulomas (>400 µm), coalescing, and caseating.
  • CD: Small granulomas (<200 µm), poorly organized, and non-caseating.

10. Perianal Disease

  • ITB: Rare.
  • CD: Common (fistulas, abscesses, skin tags).

11. Chest X-ray Findings

  • ITB: Often shows evidence of pulmonary tuberculosis in ~50% of cases.
  • CD: Normal (unless extraintestinal manifestations occur).

12. Diagnostic Tools

  • ITB:
  • Positive Ziehl-Neelsen stain for acid-fast bacilli.
  • Positive Xpert MTB/RIF PCR for TB DNA.
  • Positive Mantoux test or IGRA.
  • CD:
  • Negative for TB tests.
  • Colonoscopy with biopsy showing non-caseating granulomas.
  • Serology: ASCA (anti-Saccharomyces cerevisiae antibodies) and pANCA.

13. Response to Therapy

  • ITB: Responds well to anti-tubercular therapy (ATT) for 6–9 months.
  • CD: Requires immunosuppressive therapy (e.g., corticosteroids, biologics like anti-TNF agents).

14. Complications

  • ITB:
  • Strictures.
  • Fistulas (less common than in CD).
  • Perforation.
  • Obstruction due to mass effect.
  • CD:
  • Strictures.
  • Fistulas (common).
  • Abscess formation.
  • Perianal disease.

Key Differentiating Features

| Feature | Intestinal Tuberculosis | Crohn’s Disease |

|--------------------------|----------------------------------|----------------------------------|

| Granulomas | Caseating | Non-caseating |

| Ulcer Orientation | Transverse | Longitudinal |

| Imaging | Necrotic lymph nodes, ascites | Skip lesions, creeping fat |

| Response to Therapy | Anti-tubercular drugs | Immunosuppressives |


Clinical Pearls

  1. In tuberculosis-endemic areas, always consider ITB as a differential diagnosis for Crohn’s disease.

  2. If caseating granulomas or necrotic lymph nodes are present, ITB is more likely.

  3. A trial of anti-tubercular therapy can be diagnostic if histological differentiation is inconclusive.


Summary

Differentiating ITB from CD is crucial for initiating the correct treatment. Misdiagnosis can lead to inappropriate use of immunosuppressive therapy in ITB, which can worsen the condition. Conversely, untreated CD can lead to progressive complications.

Related Q&A

43

Small Bowel Va Large Bowel Diarrhea

When distinguishing between Small Bowel Diarrhea and Large Bowel Diarrhea, it's important to focus on their clinical features, stool characteristics, associated symptoms, and underlying causes. Below is a...

44

Blumer's Shelf

Blumer’s Shelf: A Comprehensive Overview Blumer’s shelf is a clinical sign identified during a digital rectal examination (DRE). It refers to a firm, nodular mass palpated in the...

45

Gut Neuropeptide

Gut neuropeptides are small signaling molecules produced by neurons and enteroendocrine cells within the gastrointestinal (GI) tract. They play essential roles in regulating various physiological functions, including motility,...

46

Serotonin

Serotonin: A Comprehensive Overview Serotonin, also known as 5-hydroxytryptamine (5-HT), is a biogenic amine that functions as both a neurotransmitter in the central nervous system (CNS) and a...

47

PAMPs, DAMPs and Inflammasome

PAMPs, DAMPs, and Inflammasomes: Detailed Explanation PAMPs (Pathogen-Associated Molecular Patterns), DAMPs (Damage-Associated Molecular Patterns), and inflammasomes are key players in the innate immune system, which serves as the...

48

Microvillus Inclusion Disease

Microvillus Inclusion Disease (MVID) is a rare, congenital intestinal disorder that primarily affects infants and newborns. It is caused by genetic mutations that disrupt the normal function of...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer